584 related articles for article (PubMed ID: 31920513)
1. Autophagy and LRRK2 in the Aging Brain.
Albanese F; Novello S; Morari M
Front Neurosci; 2019; 13():1352. PubMed ID: 31920513
[TBL] [Abstract][Full Text] [Related]
2. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
[TBL] [Abstract][Full Text] [Related]
4. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
[TBL] [Abstract][Full Text] [Related]
5. Mutations in LRRK2 potentiate age-related impairment of autophagic flux.
Saha S; Ash PE; Gowda V; Liu L; Shirihai O; Wolozin B
Mol Neurodegener; 2015 Jul; 10():26. PubMed ID: 26159606
[TBL] [Abstract][Full Text] [Related]
6. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
[TBL] [Abstract][Full Text] [Related]
7. Neuron-autonomous susceptibility to induced synuclein aggregation is exacerbated by endogenous
MacIsaac S; Quevedo Melo T; Zhang Y; Volta M; Farrer MJ; Milnerwood AJ
Brain Commun; 2020; 2(1):fcz052. PubMed ID: 32510053
[TBL] [Abstract][Full Text] [Related]
8. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice.
Tong Y; Yamaguchi H; Giaime E; Boyle S; Kopan R; Kelleher RJ; Shen J
Proc Natl Acad Sci U S A; 2010 May; 107(21):9879-84. PubMed ID: 20457918
[TBL] [Abstract][Full Text] [Related]
9. "LRRK2: Autophagy and Lysosomal Activity".
Madureira M; Connor-Robson N; Wade-Martins R
Front Neurosci; 2020; 14():498. PubMed ID: 32523507
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 and Proteostasis in Parkinson's Disease.
Pérez-Carrión MD; Posadas I; Solera J; Ceña V
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743250
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
O'Hara DM; Pawar G; Kalia SK; Kalia LV
Front Neurosci; 2020; 14():577. PubMed ID: 32625052
[TBL] [Abstract][Full Text] [Related]
12. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher JP
Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
[TBL] [Abstract][Full Text] [Related]
13. Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.
Sala G; Marinig D; Arosio A; Ferrarese C
Front Mol Neurosci; 2016; 9():157. PubMed ID: 28066181
[TBL] [Abstract][Full Text] [Related]
14. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice.
Novello S; Arcuri L; Dovero S; Dutheil N; Shimshek DR; Bezard E; Morari M
Neurobiol Dis; 2018 Dec; 120():21-33. PubMed ID: 30172844
[TBL] [Abstract][Full Text] [Related]
15. Autophagy and Parkinson's Disease.
Lu J; Wu M; Yue Z
Adv Exp Med Biol; 2020; 1207():21-51. PubMed ID: 32671737
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
[TBL] [Abstract][Full Text] [Related]
17. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.
López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R
J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501
[TBL] [Abstract][Full Text] [Related]
18. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA
Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
[TBL] [Abstract][Full Text] [Related]
20. Chaperon-mediated autophagy can regulate diquat-induced apoptosis by inhibiting α-synuclein accumulation cooperatively with macroautophagy.
Kim HJ; Koh HC
Food Chem Toxicol; 2021 Dec; 158():112706. PubMed ID: 34848256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
